Skip to main content
. 2015 May 28;14:217. doi: 10.1186/s12936-015-0696-1

Figure 4.

Figure 4

Cost-effectiveness plane of RDT compared with presumptive diagnosis in a low transmission region of Afghanistan, 2009: scatterplot of incremental societal costs in US$ and incremental effect of appropriately treated patients. Average incremental cost: US$2.38, average incremental effect: 0.53.